tirzepatide sleeplessness Feeling Tired on Tirzepatide: Causes and Management Is Sleeplessness a Side Effect

Feb 2 2021;143(5):e35-e71

One-year discontinuation was also higher for people who had previously used gastrointestinal medications (RR 1.09, 95% CI 1.07-1.11) or psychiatric medications (RR 1.12, 95% CI 1.10-1.14), for those with pre-existing cardiovascular disease (RR 1.10, 95% CI 1.06-1.14) or Charlson comorbidity index score 3+ (RR 1.11, 95% CI 1.05-1.17), and for users living in a low- versus high-income municipality (RR 1.15, 95% CI 1.11-1.20)

Existing studies are largely descriptive and cross-sectional in design, with few prospective investigations into disease progression, genetic susceptibility, or treatment outcomes

The empagliflozin group experienced more non-severe urinary tract infections (7 vs

More Competition: With affordability no longer a major barrier, new virtual weight loss programs will emerge, intensifying market competition